Latest news

Nanologica utökar ledningsgruppen för stärkt fokus på kromatografi

10 August, 2022

Nanologica AB (publ) utökar sin ledningsgrupp med Katarina Alenäs, SVP Chromatography, som ett led i att bolagets satsning på preparativ kromatografi intensifieras. Katarina Alenäs tillträdde sin position som SVP Chromatography hos Nanologica i början av mars och kom närmast från en roll som Business Team Manager Sweden and Finland, Country General Manager Sweden samt styrelseordförande i Agilent Technologies Sweden AB. Katarina har en gedigen bakgrund och ett starkt nätverk inom kromatografiområdet, ett område hon har

5 quick questions with Chunfang Zhou

9 August, 2022

Chunfang Zhou, Sales Manager China, Nanologica AB Who are you? My name is Chunfang Zhou and I am Nanologica’s Sales Manager in China. I am originally from China where I studied Chemical Engineering and did my PhD in Physical Chemistry. I also have a Post Doc from the University of Aveiro in Portugal. I have worked with nanoporous silica for more than 20 years, both within drug delivery and in chromatography. What is your current

5 Quick Questions with PK Dutta

30 June, 2022

P.K. DUTTA, Ph.D., SVP Sales Nanologica AB Who are you? I am a Molecular Biologist by training. I have spent most of my career dealing with large scale silica based industrial purification of peptides and small molecules. Before joining Nanologica, I held leadership and strategic roles for global silica brands like Waters, Kromasil and YMC. I am very honored to be part of the Nanologica Business Development Team, establishing a more significant presence in the

Nanologica takes out loan of MSEK 20 within agreed credit facility

27 June, 2022

Nanologica AB (publ) has taken out a loan of MSEK 20 from the credit facility agreed in January with Flerie Invest AB. The loan is taken out to cover the company’s temporary financial needs pending expected cash flows from the operations in preparative chromatography. After this loan, the credit facility has been used in full. Parts of the proceeds will be used to repay a loan from a private financier of MSEK 10 that expires

Nanologica upptar lån om 20 MSEK inom avtalad kreditfacilitet

27 June, 2022

Nanologica AB (publ) har upptagit ett lån om 20 MSEK ur den kreditfacilitet som i januari avtalades med Flerie Invest AB. Lånet upptas i syfte att överbrygga bolagets tillfälliga finansiella behov i väntan på förväntade kassaflöden från verksamheten inom preparativ kromatografi. Efter lånet har hela kreditfaciliteten nyttjats. Delar av likviden kommer att användas för att betala tillbaka ett lån från en privat finansiär om 10 MSEK som löper ut den 1 juli 2022 och som

Analytica in Munich

14 June, 2022

Next week from June 21 to 24, Nanologica will be at Analytica in Munich! Analytica is the leading industry event for analytics, laboratory technology and biotechnology. With 1,200 exhibitors, 36,000 visitors and 55,000 square meters of exhibition space, Analytica is the largest trade fair for analysis, laboratory technology and biotechnology in the world. As the industry’s definitive forum, Analytica gives visitors a comprehensive market overview and information about the latest developments in laboratory technology, analysis

About us

Nanologica is a Swedish life science group that offers advanced solutions in the development, manufacture and purification of pharmaceutical substances. By combining expertise in materials science, nanotechnology, and chemical process development, with services in contract development and manufacturing, Nanologica provides an integrated platform that supports the entire value chain from early development to commercial production of pharmaceutical substances. Nanologica’s offering enables efficient and scalable production of drug substances, with particular strength within complex molecules and peptide-based drugs, such as treatments for diabetes and obesity. The company positions itself as a long-term partner to the pharmaceutical industry, with the goal of enabling more patients around the world to have access to life-saving treatments and cost-effective medicines. The Group has about 70 employees and is headquartered in Södertälje. Nanologica’s share (ticker NICA) has been listed on Nasdaq Stockholm’s main market since 2022.

Categories

News archive